Biologically active hydroxymoyl chlorides as antifungal agents

Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry

Volumn 47, Issue 5, 2008, Pages 740-747

  Ismail, Tabasum ^a   Shafi, Syed ^a   Singh, Parvinder Pal ^a   Qazi, Naveed Ahmed ^a   Sawant, Sanghapal D ^a   Ali, Intzar ^a   Khan, Inshad Ali ^a   Kumar, H M S ^a   Qazi, Ghulam Nabi ^b   Alam, M Sarwar ^a  

^a HAMDARD UNIVERSITY   (India)

^b CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Antifungal activity; Hydroxylamine hydrochloride; Hydroxymoyl chloride (chlorooxime); N chlorosuccinimide; Oximes

Indexed keywords

EID: 48249091651     PISSN: 03764699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kontoyannis D, Mantadakis E & Samonis G, J Hosp Infect, 53, 2003, 243.
2. Garber G, Drugs, 61(Suppl. 1), 2001, 1.
3. Fidler D F, Emerg Infect Dis, 4, 1998, 169.
4. Oren I, Temiz O, Yalcin I, Sener E & Altanlar N, Eur J Pharm Sci, 7, 1999, 153.
5. Hong C Y, Farmaco. 56, 2001, 41.
6. Macchiarulo A, Constantino G, Fringuelli D, Vecchiarelli A, Schiaffella F & Fringuelli R, Bioorg Med Chem, 10, 2002, 3415.
7. Patterson T F, Lancet, 366, 2005, 1013.
8. Yanaisawa H, Takamura M, Yamada E, Fujita S, Fujiwara T, Yachi M, Isobe A & Hagisawa Y, Bioorg Med Chem Letters, 10, 2000, 373.
9. Jinda D P, Chattopadhaya R, Guleria S & Gupta R, Eur J Med Chem, 38, 2003, 1025.
10. Pillai A D, Rathod P D, Franklin P X, Padh H, Vasu K K & Sudarsanam V, Biochem Biophys Res Commun, 317, 2004, 1067.
11. Mantylla A, Rautio J, Nevalainen T, Vepsalainen J, Juvonen R, Kendrick H, Gamier T, Croftd S L & Jarvinen T, Bioorg Med Chem, 12, 2004, 3497.
12. Huang S, Li R, Connolly P, Xu G, Gaul M D, Emanuel S L, LaMontagnea K R & Greenberger L M, Bioorg Med Chem Letters, 16, 2006, 6063.
13. Minutolo F, Antonello M, Bertini S, Rapposelli S, Rossello A, Sheng S, Carlson E K, Katzenellenbogenc J A & Macchiaa M, Bioorg Med Chem, 11 , 2003, 1247.
14. (a) Serrano-wu M H, St Laurent D R, Mazzucco C E, Stickle T M, Barrett J F, Vyas D M & Balasubramanian B N, Bioorg Med Chem Letters, 12, 2002, 943;
15. (b) Emami S, Falahati M, Banifatemi A, Moshiri A & Shafiee A, Arch Pharm Pharm Med Chem, 7, 2002, 318.
16. Liu K C, Shelton B R & Howe R K, J Org Chem, 45, 1980, 3916.
17. (a) Johnson W H, Roberts N A & Borkakoti N, J Enzyme Inhib, 2, 1987, 1;
18. (b) Whittaker M & Brown P, Curr Opin Drug Discov Dev, 1, 1998, 157;
19. (c) Bottomley K M, Johnson W H & Walter D S, J Enzym Inhib, 13, 1998, 79.
20. Gupta & Shyam K, (Scottsdale, AZ) US Patent, 711775, 04/ 06/ 2006, Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition.
21. National Committee for Clinical Laboratory Standards. 1997 Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard M27-A National Committee for Clinical Laboratory Standards, Wayne, Pa. 19 National Committee for Clinical Laboratory Standards. 1998 Reference method for broth dilution antifungal susceptibility testing of conidium forming fungi; proposed standard M38-P National Committee for Clinical Laboratory Standards, Wayne, Pa.